Jonathan DrachmanSenior VP Seattle Genetics
George PettitRegents Professor of Chemistry Arizona State University
Dennis BenjaminVice President, Experimental Therapeutics Seattle Genetics
Jan PinkasDirector ImmunoGen
This October, ADC leaders across the globe will convene to share unpublished findings at World ADC San Francisco 2013, the focal point for everyone working on ADCs. That’s over 500 senior ADC scientists and professionals challenging the most advanced scientific thinking.
This year’s overarching theme is translational science. The number of ADCs entering the pipeline is increasing and critical data is now being uncovered enabling better predictions of how these therapies will perform in the clinic and ultimately make it to market. At World ADC San Francisco, learn from 65 speakers from more than 40 organizations and leave the meeting with all the tools, knowledge and ideas to design and develop the optimal ADC, faster.
“One of the best learning experiences. This meeting has solved several questions I did not know how to solve prior. Furthermore, I have thought of a new ADC project that might be useful for my company”
World ADC San Francisco 2013 will cover the latest data and insights fresh from the frontline:
With so many new insights to include this year, you can take advantage of 3 individual streams highlighting the most innovative projects in the ADC field. Pick and choose talks from “ADC Discovery”, “Development Approaches” and “Optimizing CMC” to learn everything you’ve ever wanted to know about antibody-drug conjugate development.
"Meet the world experts in the ADC field and join the most exciting community of empowered Biotherapeutics”
Why not join our community on LinkedIn and join over 2000 of your peers - start discussions, find answers and make new contacts. Simply search LinkedIn groups Antibody Drug Conjugates.
"Great meeting. I have been working in this field for over 10 years, this meeting brings the best scientists with state of the art experience. Finally a meeting where we can focus on just ADC. Great Job" Bristol-Myers Squibb
"THE best opportunity to meet the pioneers in the field of ADC" AstraZeneca
"Meet the world experts in the ADC field and join the most exciting community of empowered biotheraputics Genentech